- Home
- ZVIA vs SCPH Comparison
ZVIA vs SCPH Comparison
Compare ZVIA & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- SCPH
- Stock Information
- Founded
- ZVIA 2007
- SCPH 2013
- Country
- ZVIA United States
- SCPH United States
- Employees
- ZVIA N/A
- SCPH N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- ZVIA Consumer Staples
- SCPH Health Care
- Exchange
- ZVIA Nasdaq
- SCPH Nasdaq
- Market Cap
- ZVIA 166.5M
- SCPH 173.6M
- IPO Year
- ZVIA 2021
- SCPH 2017
- Fundamental
- Price
- ZVIA $3.14
- SCPH $3.84
- Analyst Decision
- ZVIA Hold
- SCPH Strong Buy
- Analyst Count
- ZVIA 2
- SCPH 3
- Target Price
- ZVIA $3.38
- SCPH $14.00
- AVG Volume (30 Days)
- ZVIA 523.9K
- SCPH 289.6K
- Earning Date
- ZVIA 08-06-2025
- SCPH 08-13-2025
- Dividend Yield
- ZVIA N/A
- SCPH N/A
- EPS Growth
- ZVIA N/A
- SCPH N/A
- EPS
- ZVIA N/A
- SCPH N/A
- Revenue
- ZVIA $154,273,000.00
- SCPH $41,982,000.00
- Revenue This Year
- ZVIA $5.66
- SCPH $108.95
- Revenue Next Year
- ZVIA $6.76
- SCPH $73.83
- P/E Ratio
- ZVIA N/A
- SCPH N/A
- Revenue Growth
- ZVIA N/A
- SCPH 138.10
- 52 Week Low
- ZVIA $0.62
- SCPH $1.94
- 52 Week High
- ZVIA $4.99
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- ZVIA 63.24
- SCPH 56.83
- Support Level
- ZVIA $2.89
- SCPH $3.86
- Resistance Level
- ZVIA $3.27
- SCPH $4.17
- Average True Range (ATR)
- ZVIA 0.19
- SCPH 0.23
- MACD
- ZVIA 0.04
- SCPH -0.06
- Stochastic Oscillator
- ZVIA 76.79
- SCPH 33.33
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.